Utilizing data-driven insights for digital health solutions
Digital health technologies are changing how care is delivered, but how do we substantiate claims that these innovations are effective?…
Digital health technologies are changing how care is delivered, but how do we substantiate claims that these innovations are effective?…
The rare disease landscape poses myriad challenges for researchers, policymakers, and CROs, particularly in navigating its intricate regulatory environment. Rare…
Clinical trials for oncology are filled with data management complexities that must be carefully navigated, with challenges and solutions outlined…
The active pharmaceutical ingredient (API) landscape is shifting. Companies are rethinking their sourcing strategies, upgrading their technological capabilities, and relying…
Projections show a $177.46 billion market by 2034 and an 18.7% CAGR. But here's the reality check: current manufacturing capacity…
The use of mRNA in therapeutics is growing ever wider following its success in Moderna’s and BioNTech’s Covid-19 vaccine programmes.…
This article explores the typical fill-finish process, the potential impact on unstable drug products, and best practices to protect these…
For decades, intravenous (IV) infusions in clinical settings were the standard for therapies such as monoclonal antibodies. Today, advances in…
Dr. Zamilpa is the Executive Director of Biomanufacturing and Collaborative Programs at BBG Advanced Therapies, a subsidiary of BioBridge Global…
Pharmaceutical companies are striving to balance complex and evolving regulatory demands, operational efficiency challenges, and environmental responsibility in an age…